In 2016, we applied for two PCTs, i.e. "colistin biosynthesis gene cluster" and "Application of anti tuberculosis bacteria". In 2018, we applied for "colistin anti-tumor application" PCT, and next year, we are going to apply for another patent similar to compound protection of PCT<br>
正在翻译中..